From our experience as a Contract Research Organization (CRO) working across multiple therapeutic areas and regions, here are the key lessons business owners must understand before investing in Biosimilar Clinical Trials. Why Are Biosimilar Clinical Trials Necessary When the Reference…
As the patents for blockbuster biologics expire, a new era of opportunity emerges, ushering in the rise of biosimilars. These biologic alternatives offer the promise of affordable care, broader global access, and lucrative growth for pharmaceutical companies. But the key…
Efficient biosimilar clinical trials in India follow regulatory guidelines, structured processes, key benefits, and data standards for USFDA and EMA submissions. Biosimilar clinical trials in India are witnessing growing global attention amid a significant surge in the development of biosimilars,…
Biostatistics involves the application of statistical techniques for the design and analysis of clinical trial data. In addition to the conduct of trials which encompasses regulatory approval processes, informed consent, and patient monitoring, and safety, it is necessary to ensure…
Biologicals products occupy a significant place in the treatment landscape of several autoimmune diseases and cancers and are most often the only choice of treatment and management of several diseases but are associated with and are limited in their usage…
The rising prevalence and large market share of biological products emphasize their importance as treatment options for several cancers and autoimmune diseases. In contrast to chemically synthesized molecules, biologicals are large and complex due to their natural origin with complicated…